[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Dacarbazine.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Dacarbazine.]
[J01GA01, streptomycin, Dacarbazine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Dacarbazine.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Dacarbazine.]
[L04AA27, fingolimod, Dacarbazine may increase the immunosuppressive activities of Fingolimod.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01CG01, sulbactam, Dacarbazine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Dacarbazine.]
[M04AB02, sulfinpyrazone, The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Dacarbazine.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Mercaptopurine.]
[N06DA01, tacrine, The metabolism of Dacarbazine can be decreased when combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Dacarbazine can be decreased when combined with Tamoxifen.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Teniposide is combined with Dacarbazine.]
[R03CC03, terbutaline, Dacarbazine may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Dacarbazine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Tetracaine.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[A04AD10, dronabinol, The metabolism of Dacarbazine can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Dacarbazine can be decreased when combined with Theophylline.]
[P02CA02, thiabendazole, The metabolism of Dacarbazine can be decreased when combined with Thiabendazole.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Eribulin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Dacarbazine.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Dacarbazine.]
[G04BE06, moxisylyte, Dacarbazine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Dacarbazine may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Dacarbazine can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[P01AB02, tinidazole, Dacarbazine may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Dacarbazine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[V04CA01, tolbutamide, Dacarbazine may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Dacarbazine.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dacarbazine.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Dacarbazine.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Dacarbazine may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Dacarbazine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The metabolism of Dacarbazine can be decreased when combined with Trifluoperazine.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Dacarbazine.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Mometasone is combined with Dacarbazine.]
[A03AA05, trimebutine, Dacarbazine may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Dacarbazine.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Belimumab.]
[L01FX04, ipilimumab, Dacarbazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Dacarbazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The serum concentration of Dacarbazine can be increased when it is combined with Abiraterone.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Dacarbazine.]
[S01AA28, vancomycin, Dacarbazine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Belatacept.]
[N03AX21, ezogabine, Dacarbazine may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Dacarbazine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The risk or severity of bleeding can be increased when Ticagrelor is combined with Dacarbazine.]
[C08DA01, verapamil, The metabolism of Dacarbazine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Dacarbazine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Vinblastine is combined with Dacarbazine.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Vincristine is combined with Dacarbazine.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Dacarbazine.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Dacarbazine.]
[B01AA03, warfarin, The metabolism of Dacarbazine can be decreased when combined with Warfarin.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dacarbazine.]
[L01EC01, vemurafenib, The serum concentration of Dacarbazine can be increased when it is combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Brentuximab vedotin.]
[M05BA05, tiludronic acid, Dacarbazine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Dacarbazine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Dacarbazine.]
[A02BC04, rabeprazole, Dacarbazine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[J01MA13, trovafloxacin, The metabolism of Dacarbazine can be decreased when combined with Trovafloxacin.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Dacarbazine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Dacarbazine.]
[N02BA01, aspirin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Dacarbazine.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ruxolitinib.]
[G04BD07, tolterodine, Dacarbazine may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Dacarbazine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dacarbazine.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Dacarbazine.]
[M01CB03, auranofin, Dacarbazine may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Dacarbazine.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Dacarbazine.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dacarbazine.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Dacarbazine.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dacarbazine.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Dacarbazine.]
[G04BD12, mirabegron, Dacarbazine may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Carfilzomib.]
[L02BB04, enzalutamide, Dacarbazine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Bosutinib.]
[L04AA31, teriflunomide, The serum concentration of Dacarbazine can be decreased when it is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Dacarbazine.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Aldosterone.]
[D02BA02, octinoxate, Dacarbazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Bendamustine.]
[N04BD02, rasagiline, The metabolism of Rasagiline can be decreased when combined with Dacarbazine.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Dacarbazine.]
[L04AA29, tofacitinib, Dacarbazine may increase the immunosuppressive activities of Tofacitinib.]
[N02CC03, zolmitriptan, The metabolism of Dacarbazine can be decreased when combined with Zolmitriptan.]
[V09IX04, fluorodeoxyglucose F18, Dacarbazine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[V08CA11, gadofosveset, Dacarbazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ponatinib.]
[B01AF02, apixaban, The risk or severity of bleeding can be increased when Apixaban is combined with Dacarbazine.]
[A16AX08, teduglutide, Dacarbazine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Dacarbazine may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Dacarbazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Pomalidomide.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Dimethyl fumarate.]
[J01MA15, gemifloxacin, The metabolism of Dacarbazine can be decreased when combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The metabolism of Dacarbazine can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The metabolism of Dacarbazine can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Benzocaine.]
[L03AA12, ancestim, Dacarbazine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Everolimus.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01EE01, trametinib, Dacarbazine may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Dacarbazine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Dacarbazine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[L03AA14, lipegfilgrastim, Dacarbazine may increase the myelosuppressive activities of Lipegfilgrastim.]
[A10BJ03, lixisenatide, Dacarbazine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Dacarbazine may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ibrutinib.]
[N06AX26, vortioxetine, Dacarbazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J05AP05, simeprevir, The metabolism of Dacarbazine can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Dacarbazine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The metabolism of Dacarbazine can be decreased when combined with Dapagliflozin.]
[C01CA27, droxidopa, Dacarbazine may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Dacarbazine.]
[L04AA32, apremilast, The metabolism of Dacarbazine can be increased when combined with Apremilast.]
[L02BG02, formestane, Dacarbazine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Dacarbazine.]
[S01ED02, betaxolol, The metabolism of Dacarbazine can be decreased when combined with Betaxolol.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Dacarbazine.]
[V03AB34, fomepizole, Dacarbazine may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[L04AC11, siltuximab, The metabolism of Dacarbazine can be increased when combined with Siltuximab.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Vorapaxar is combined with Dacarbazine.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Vedolizumab.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Dacarbazine.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Belinostat.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Idelalisib.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Decitabine.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Pirfenidone.]
[S03AA06, gentamicin, Dacarbazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Blinatumomab.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Olaparib.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Dicoumarol is combined with Dacarbazine.]
[B01AF03, edoxaban, Dacarbazine may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The metabolism of Dacarbazine can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Dacarbazine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Palbociclib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Panobinostat.]
[N02BE01, acetaminophen, The metabolism of Dacarbazine can be decreased when combined with Acetaminophen.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Dacarbazine.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Tioclomarol is combined with Dacarbazine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Dacarbazine.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB37, idarucizumab, Dacarbazine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Trabectedin.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Mepolizumab.]
[L01EB04, osimertinib, The serum concentration of Dacarbazine can be decreased when it is combined with Osimertinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Dacarbazine.]
[L01XG03, ixazomib, Dacarbazine may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[M04AB05, lesinurad, Dacarbazine may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N03AX23, brivaracetam, Dacarbazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ixekizumab.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Dacarbazine.]
[A02AD05, aluminum magnesium silicate, Dacarbazine may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[A05AA04, obeticholic acid, The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Dacarbazine.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Bupivacaine.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Arsenic trioxide.]
[M02AA03, clofezone, Dacarbazine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Dacarbazine.]
[L01XK03, rucaparib, The metabolism of Dacarbazine can be decreased when combined with Rucaparib.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Brodalumab.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Dacarbazine.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Dacarbazine.]
[A06AH05, naldemedine, Dacarbazine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Dacarbazine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06BC01, caffeine, The metabolism of Dacarbazine can be decreased when combined with Caffeine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Dacarbazine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Dacarbazine.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Dacarbazine.]
[J05AF06, abacavir, Dacarbazine may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Dacarbazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Dacarbazine can be increased when combined with Infliximab.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Sarilumab.]
[J01MA23, delafloxacin, Dacarbazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Dacarbazine.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Dacarbazine can be decreased when combined with Enasidenib.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Vorinostat.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Dacarbazine can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Dacarbazine.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Dacarbazine.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Dacarbazine.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Dacarbazine.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Dacarbazine may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[L02BB05, apalutamide, Dacarbazine may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dacarbazine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Dacarbazine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Dacarbazine.]
[N03AX24, cannabidiol, The metabolism of Dacarbazine can be decreased when combined with Cannabidiol.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Baricitinib.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Dacarbazine.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01GB14, plazomicin, Dacarbazine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[A16AX14, migalastat, Dacarbazine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Dacarbazine can be decreased when combined with Stiripentol.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Dacarbazine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Dacarbazine.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AA39, emapalumab, The metabolism of Dacarbazine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Dacarbazine.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ravulizumab.]
[A06AX05, prucalopride, Dacarbazine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Dacarbazine.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Dacarbazine.]
[P02BX04, triclabendazole, The metabolism of Dacarbazine can be decreased when combined with Triclabendazole.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Siponimod.]
[N06BA14, solriamfetol, Dacarbazine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Cloprednol.]
[L04AB01, etanercept, The metabolism of Dacarbazine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Risankizumab.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Dacarbazine.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Upadacitinib.]
[N07XX11, pitolisant, The metabolism of Dacarbazine can be increased when combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Dacarbazine.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE03, insulin, regular, pork, The metabolism of Dacarbazine can be increased when combined with Insulin pork.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Dacarbazine.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Trastuzumab emtansine.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Diroximel fumarate.]
[A16AX16, givosiran, The serum concentration of Dacarbazine can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Dacarbazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Dacarbazine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Teprotumumab.]
[M01AX21, diacetylrhein, The metabolism of Dacarbazine can be decreased when combined with Diacerein.]
[S01AE06, gatifloxacin, The metabolism of Dacarbazine can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The serum concentration of Dacarbazine can be increased when it is combined with Osilodrostat.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Dacarbazine.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Dacarbazine.]
[R02AA03, dichlorobenzyl alcohol, Dacarbazine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Dacarbazine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, The metabolism of Dacarbazine can be decreased when combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Dacarbazine.]
[C08CA16, clevidipine, Dacarbazine may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Dacarbazine.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Dacarbazine.]
[L01EX17, capmatinib, The serum concentration of Dacarbazine can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluprednidene.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[V08CA05, mangafodipir, Dacarbazine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Dacarbazine.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Dacarbazine is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Stepronin.]
[L04AC19, satralizumab, The serum concentration of Dacarbazine can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, The metabolism of Dacarbazine can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The metabolism of Dacarbazine can be decreased when combined with Chlorzoxazone.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N02BA03, choline salicylate, Dacarbazine may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fludarabine.]
[M01AX25, chondroitin sulfates, Dacarbazine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Dacarbazine can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, The metabolism of Dacarbazine can be increased when combined with Trilaciclib.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Dacarbazine.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01MB07, flumequine, The metabolism of Dacarbazine can be decreased when combined with Flumequine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Dacarbazine.]
[N02BG07, flupirtine, Dacarbazine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ponesimod.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Dacarbazine can be increased when it is combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Dacarbazine can be decreased when combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Dacarbazine can be decreased when combined with Cinnarizine.]
[J01MB06, cinoxacin, The metabolism of Dacarbazine can be decreased when combined with Cinoxacin.]
[S03AA07, ciprofloxacin, The metabolism of Dacarbazine can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Dacarbazine.]
[N06AB04, citalopram, The metabolism of Dacarbazine can be decreased when combined with Citalopram.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Pegcetacoplan.]
[H01AC07, somapacitan, The metabolism of Dacarbazine can be increased when combined with Somapacitan.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Dacarbazine can be decreased when combined with Fexinidazole.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Anifrolumab.]
[H01AC09, lonapegsomatropin, The metabolism of Dacarbazine can be increased when combined with Lonapegsomatropin.]
[V09AB03, ioflupane I-123, Dacarbazine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Dacarbazine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Dacarbazine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ropeginterferon alfa-2b.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Dacarbazine.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Dacarbazine can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Dacarbazine.]
[N03AE01, clonazepam, Dacarbazine may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The metabolism of Dacarbazine can be decreased when combined with Clonidine.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Deucravacitinib.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Dacarbazine.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Dacarbazine is combined with Clozapine.]
[J01GB12, arbekacin, Dacarbazine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Dacarbazine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Dacarbazine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M04AC01, colchicine, Dacarbazine may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Dacarbazine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Leflunomide.]
[A04AA03, tropisetron, Dacarbazine may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Nelarabine.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Dacarbazine.]
[J05AB14, valganciclovir, Dacarbazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Dacarbazine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Dacarbazine may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Dacarbazine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Dacarbazine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Dacarbazine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N02CC05, almotriptan, Dacarbazine may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Dacarbazine.]
[S01AD03, acyclovir, The metabolism of Dacarbazine can be decreased when combined with Acyclovir.]
[N05BA10, ketazolam, Dacarbazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Imatinib is combined with Dacarbazine.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dacarbazine.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Dacarbazine.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be decreased when combined with Dacarbazine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Dacarbazine may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Meprednisone.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Dacarbazine may decrease the excretion rate of Melperone which could result in a higher serum level.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Dacarbazine.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Dacarbazine.]
[S01XA18, cyclosporine, Dacarbazine may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Dacarbazine can be increased when combined with Armodafinil.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Dacarbazine can be decreased when combined with Entecavir.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Dacarbazine.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Antilymphocyte immunoglobulin (horse).]
[J01MB04, pipemidic acid, The metabolism of Dacarbazine can be decreased when combined with Pipemidic acid.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Dacarbazine.]
[M01AG01, mefenamic acid, The metabolism of Dacarbazine can be decreased when combined with Mefenamic acid.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Dactinomycin.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dacarbazine.]
[M01AX01, nabumetone, The metabolism of Dacarbazine can be decreased when combined with Nabumetone.]
[N07BB05, nalmefene, Dacarbazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06AX06, nefazodone, Dacarbazine may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Dacarbazine may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Dacarbazine.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dacarbazine.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06AA01, desipramine, Dacarbazine may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Dacarbazine.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dacarbazine.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Dexamethasone.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Dacarbazine.]
[L04AB04, adalimumab, The metabolism of Dacarbazine can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06AB05, paroxetine, The metabolism of Dacarbazine can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Dacarbazine can be decreased when combined with Clopidogrel.]
[C01DA05, pentaerythritol tetranitrate, Dacarbazine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Dacarbazine.]
[P03AC04, permethrin, Dacarbazine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Cinchocaine.]
[R05DA08, pholcodine, Dacarbazine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The metabolism of Dacarbazine can be decreased when combined with Diclofenac.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J05AF02, didanosine, Dacarbazine may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Dacarbazine can be decreased when combined with Erlotinib.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Pirarubicin.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Difluocortolone.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C01AA05, digoxin, Dacarbazine may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, The metabolism of Dacarbazine can be decreased when combined with Dihydralazine.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Dacarbazine.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Dacarbazine.]
[J05AE08, atazanavir, The metabolism of Dacarbazine can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, Dacarbazine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Pramocaine.]
[V03AB09, dimercaprol, Dacarbazine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Dacarbazine may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Dacarbazine.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Proparacaine.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Dacarbazine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Diphenhydramine.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Dacarbazine.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Dacarbazine.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Sirolimus.]
[S01AX06, resorcinol, Dacarbazine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The metabolism of Dacarbazine can be decreased when combined with Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Natalizumab.]
[S02AA12, rifamycin SV, The metabolism of Dacarbazine can be decreased when combined with Rifamycin.]
[N07XX02, riluzole, The metabolism of Dacarbazine can be decreased when combined with Riluzole.]
[R06AE09, levocetirizine, Dacarbazine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Dacarbazine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Dacarbazine can be decreased when combined with Rosoxacin.]
[L01EX01, sunitinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Sunitinib.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Dacarbazine.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Dacarbazine.]
[C01CA04, dopamine, Dacarbazine may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA16, dothiepin, The metabolism of Dacarbazine can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Dacarbazine.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Doxorubicin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[A08AA10, sibutramine, Dacarbazine may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Dacarbazine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[V04CX07, edrophonium, Dacarbazine may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Corticotropin.]
[J01MA05, temafloxacin, The metabolism of Dacarbazine can be decreased when combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Temozolomide.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Dacarbazine.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06AG03, toloxatone, Dacarbazine may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Dacarbazine.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Trilostane.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Dacarbazine.]
[J01MA04, enoxacin, The metabolism of Dacarbazine can be decreased when combined with Enoxacin.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dacarbazine.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Dacarbazine.]
[N05CF02, zolpidem, The metabolism of Dacarbazine can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Dacarbazine.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Dacarbazine.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Carboplatin.]
[C02AC02, guanfacine, Dacarbazine may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[B01AC11, iloprost, The risk or severity of bleeding can be increased when Iloprost is combined with Dacarbazine.]
[L03AX05, pidotimod, Dacarbazine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Dacarbazine may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Dacarbazine.]
[G03CA03, estradiol, The metabolism of Dacarbazine can be decreased when combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Estramustine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Dacarbazine can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Dacarbazine can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluticasone.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Dacarbazine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01CB01, etoposide, The risk or severity of adverse effects can be increased when Etoposide is combined with Dacarbazine.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Dacarbazine.]
[P01AX07, trimetrexate, Dacarbazine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Dacarbazine may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Dacarbazine can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, The metabolism of Dacarbazine can be decreased when combined with Tocainide.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Dacarbazine.]
[M01CB01, gold sodium thiomalate, Dacarbazine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Dacarbazine may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Dacarbazine.]
[A02BA03, famotidine, The metabolism of Dacarbazine can be decreased when combined with Famotidine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Dacarbazine can be increased when combined with Albendazole.]
[N03AX26, fenfluramine, The metabolism of Dacarbazine can be decreased when combined with Fenfluramine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[R03CC02, albuterol, Dacarbazine may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Dacarbazine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dacarbazine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Dacarbazine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G04BD02, flavoxate, Dacarbazine may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Dacarbazine.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Dacarbazine.]
[V03AB25, flumazenil, Dacarbazine may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Dacarbazine.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluocinonide.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Ethanol can be decreased when combined with Dacarbazine.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Dacarbazine.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Dacarbazine.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Dacarbazine.]
[N06AB03, fluoxetine, The metabolism of Dacarbazine can be decreased when combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Dacarbazine.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L02BB01, flutamide, The metabolism of Dacarbazine can be decreased when combined with Flutamide.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Dacarbazine.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01AD09, ganciclovir, Dacarbazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, The metabolism of Dacarbazine can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Dacarbazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Dasatinib.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Dacarbazine.]
[A10BB07, glipizide, Dacarbazine may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, The metabolism of Dacarbazine can be decreased when combined with Dexmedetomidine.]
[L01EX02, sorafenib, The serum concentration of 5-amino-imidazole-4-carboxamide (AIC), an active metabolite of Dacarbazine, can be increased when used in combination with Sorafenib.]
[M01CB04, aurothioglucose, Dacarbazine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Dacarbazine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Fluindione is combined with Dacarbazine.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01EX01, guanethidine, Dacarbazine may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N05AD01, haloperidol, The metabolism of Dacarbazine can be decreased when combined with Haloperidol.]
[N05AH04, quetiapine, Dacarbazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Dacarbazine may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Irinotecan is combined with Dacarbazine.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Dacarbazine.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Dacarbazine.]
[G03DC01, allylestrenol, Dacarbazine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Dacarbazine.]
[J05AG01, nevirapine, The metabolism of Dacarbazine can be decreased when combined with Nevirapine.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Nimesulide is combined with Dacarbazine.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C02DB02, hydralazine, Dacarbazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Dacarbazine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G04BD06, propiverine, Dacarbazine may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Hydroxychloroquine.]
[B05AA07, hetastarch, Dacarbazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Hydroxyurea.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[B05XA08, sodium acetate, Dacarbazine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Dacarbazine.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ifosfamide.]
[H01AC02, somatrem, The metabolism of Dacarbazine can be increased when combined with Somatrem.]
[N06AA02, imipramine, The metabolism of Dacarbazine can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Paclitaxel.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Tixocortol.]
[M03BX02, tizanidine, The metabolism of Dacarbazine can be decreased when combined with Tizanidine.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Topotecan.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Dacarbazine.]
[A11HA07, inositol, Dacarbazine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Dacarbazine.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Dacarbazine.]
[N06AX17, milnacipran, Dacarbazine may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Dacarbazine may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Articaine.]
[A10BH01, sitagliptin, Dacarbazine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Dacarbazine.]
[L01XX35, anagrelide, The metabolism of Dacarbazine can be decreased when combined with Anagrelide.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Dacarbazine.]
[V03AB01, ipecac, Dacarbazine may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[J05AB13, penciclovir, The metabolism of Dacarbazine can be decreased when combined with Penciclovir.]
[J04AC01, isoniazid, The metabolism of Dacarbazine can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Dacarbazine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[D10BA01, isotretinoin, Dacarbazine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Dacarbazine.]
[S01AA24, kanamycin, Dacarbazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The metabolism of Dacarbazine can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Dacarbazine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Dacarbazine may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Dacarbazine.]
[B01AC22, prasugrel, The risk or severity of bleeding can be increased when Prasugrel is combined with Dacarbazine.]
[J02AB02, ketoconazole, The metabolism of Dacarbazine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Dacarbazine can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[V03AC03, deferasirox, The serum concentration of Dacarbazine can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Dacarbazine can be increased when combined with Abatacept.]
[J01MB02, nalidixic acid, The metabolism of Dacarbazine can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N04BB01, amantadine, Dacarbazine may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AX03, lubiprostone, Dacarbazine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Dacarbazine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Lidocaine.]
[S01AA21, amikacin, Dacarbazine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Dacarbazine can be increased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Lomustine.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Dacarbazine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Dacarbazine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Pralatrexate.]
[L01EA03, nilotinib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Dacarbazine.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Dacarbazine.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Dacarbazine.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Dacarbazine.]
[N05CH01, melatonin, The metabolism of Melatonin can be decreased when combined with Dacarbazine.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Melphalan.]
[N06DX01, memantine, Dacarbazine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N03AB04, mephenytoin, The metabolism of Dacarbazine can be decreased when combined with Mephenytoin.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Mepivacaine.]
[G04BX16, tiopronin, Dacarbazine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Dacarbazine may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06BA03, methamphetamine, Dacarbazine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The risk or severity of adverse effects can be increased when Methimazole is combined with Dacarbazine.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Pemetrexed is combined with Dacarbazine.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Methotrexate is combined with Dacarbazine.]
[D05BA02, methoxsalen, The metabolism of Dacarbazine can be decreased when combined with Methoxsalen.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Dacarbazine may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, The metabolism of Dacarbazine can be increased when combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Dacarbazine.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Methylprednisolone.]
[G03EK01, methyltestosterone, Dacarbazine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Dacarbazine.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[V04CD01, metyrapone, Dacarbazine may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Dacarbazine can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Dacarbazine.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Dacarbazine.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Dacarbazine.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Dacarbazine.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dacarbazine.]
[C01BD01, amiodarone, The metabolism of Dacarbazine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Dacarbazine can be decreased when combined with Amitriptyline.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Dacarbazine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Dacarbazine.]
[G04BA01, ammonium chloride, Dacarbazine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Ofatumumab.]
[L01EX03, pazopanib, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Pazopanib.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Mycophenolic acid.]
[N03AB05, fosphenytoin, The metabolism of Dacarbazine can be increased when combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Dacarbazine.]
[C07AA12, nadolol, Dacarbazine may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, Dacarbazine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[J01CF06, nafcillin, The metabolism of Dacarbazine can be increased when combined with Nafcillin.]
[V03AB15, naloxone, Dacarbazine may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[L04AC03, anakinra, The metabolism of Dacarbazine can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M02AA12, naproxen, The metabolism of Dacarbazine can be decreased when combined with Naproxen.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Dacarbazine.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Docetaxel.]
[S03AA01, neomycin, Dacarbazine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Dacarbazine.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L03AX16, plerixafor, Dacarbazine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Dacarbazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Dacarbazine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C01CE01, inamrinone, Dacarbazine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Dacarbazine.]
[P02DA01, niclosamide, The metabolism of Dacarbazine can be decreased when combined with Niclosamide.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Dacarbazine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N05CF03, zaleplon, Dacarbazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01AE02, norfloxacin, The metabolism of Dacarbazine can be decreased when combined with Norfloxacin.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Dacarbazine.]
[L03AB07, interferon beta-1a, The metabolism of Dacarbazine can be decreased when combined with Interferon beta-1a.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Dacarbazine.]
[L04AC04, rilonacept, The metabolism of Dacarbazine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Dacarbazine can be increased when combined with Omeprazole.]
[N02AA02, opium, Dacarbazine may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Dacarbazine.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Dacarbazine.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N05AH05, asenapine, The metabolism of Asenapine can be decreased when combined with Dacarbazine.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Dacarbazine.]
[J04AB30, capreomycin, Dacarbazine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Paramethasone.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01MA03, pefloxacin, The metabolism of Dacarbazine can be decreased when combined with Pefloxacin.]
[G04BD11, fesoterodine, Dacarbazine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Dacarbazine may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Penicillamine.]
[J01CE09, penicillin G procaine, Dacarbazine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Dacarbazine.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Dacarbazine.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Dacarbazine.]
[C04AD03, pentoxifylline, The metabolism of Dacarbazine can be decreased when combined with Pentoxifylline.]
[N05AB03, perphenazine, The metabolism of Dacarbazine can be decreased when combined with Perphenazine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Dacarbazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Dacarbazine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Phenindione is combined with Dacarbazine.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Phenprocoumon is combined with Dacarbazine.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[S01GA05, phenylephrine, The metabolism of Dacarbazine can be increased when combined with Phenylephrine.]
[L04AB06, golimumab, The metabolism of Dacarbazine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Dacarbazine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Dacarbazine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C08CX01, mibefradil, The metabolism of Dacarbazine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Dacarbazine.]
[C07AA03, pindolol, Dacarbazine may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N06BX03, piracetam, Dacarbazine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J01MA11, grepafloxacin, The metabolism of Dacarbazine can be decreased when combined with Grepafloxacin.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Dacarbazine.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Dacarbazine.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[A03AE01, alosetron, The metabolism of Dacarbazine can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Dacarbazine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The metabolism of Dacarbazine can be increased when combined with Ritonavir.]
[A10BH03, saxagliptin, Dacarbazine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Dacarbazine.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Prednisone is combined with Dacarbazine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Dacarbazine can be increased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Dacarbazine can be increased when combined with Primidone.]
[M04AB01, probenecid, Dacarbazine may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Dacarbazine may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Procarbazine.]
[C10AB05, fenofibrate, Dacarbazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AA03, promazine, The metabolism of Dacarbazine can be decreased when combined with Promazine.]
[R06AD02, promethazine, Dacarbazine may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, The metabolism of Dacarbazine can be decreased when combined with Propafenone.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[C07AA05, propranolol, The metabolism of Dacarbazine can be decreased when combined with Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Dacarbazine.]
[N02CC04, rizatriptan, Dacarbazine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Epoprostenol is combined with Dacarbazine.]
[N07XX07, dalfampridine, Dacarbazine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Dacarbazine may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Dacarbazine.]
[C01BA01, quinidine, The metabolism of Dacarbazine can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Dacarbazine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Dacarbazine.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Dacarbazine can be increased when combined with Rifampicin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dacarbazine.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Dacarbazine.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Obinutuzumab.]
[J01GB08, sisomicin, Dacarbazine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Dacarbazine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Dacarbazine.]
[V04CC01, sorbitol, Dacarbazine may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[L01CD04, cabazitaxel, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Cabazitaxel.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Dacarbazine.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CH02, indigo carmine, Dacarbazine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[N05CC01, chloral hydrate, Dacarbazine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N03AG01, valproic acid, The metabolism of Dacarbazine can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Dacarbazine is combined with Hydrocortisone butyrate.]
[C01DA14, isosorbide mononitrate, Dacarbazine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
